Year |
Citation |
Score |
2023 |
Lubanska D, Alrashed S, Oschanney L, Cieslukowski A, Nadi A, Habashy P, Renaud A, Roye-Azar A, Soliman M, Adili K, Baker A, Baseet M, Llancari A, Mitrevski A, Mouawad S, et al. E-learning and research experience exchange in the online setting of student peer mentor network during COVID-19 pandemic and beyond: A laboratory case study. Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology. PMID 37811972 DOI: 10.1002/bmb.21792 |
0.463 |
|
2022 |
Fidalgo da Silva E, Abu Khatir B, Drouillard C, Hinch I, Davis GO, Sameem M, Patel R, Fong J, Lubanska D, Porter LA. Tuberin levels during cellular differentiation in brain development. Differentiation; Research in Biological Diversity. 130: 43-50. PMID 36608575 DOI: 10.1016/j.diff.2022.12.004 |
0.606 |
|
2022 |
Lubanska D, Alrashed S, Mason GT, Nadeem F, Awada A, DiPasquale M, Sorge A, Malik A, Kojic M, Soliman MAR, deCarvalho AC, Shamisa A, Kulkarni S, Marquardt D, Porter LA, et al. Impairing proliferation of glioblastoma multiforme with CD44+ selective conjugated polymer nanoparticles. Scientific Reports. 12: 12078. PMID 35840697 DOI: 10.1038/s41598-022-15244-0 |
0.586 |
|
2021 |
Lubanska D, Qemo I, Byrne M, Matthews KN, Fifield BA, Brown J, da Silva EF, Porter LA. The Cyclin-Like Protein SPY1 overrides Reprogramming Induced Senescence Through EZH2 Mediated H3K27me3. Stem Cells (Dayton, Ohio). PMID 34486784 DOI: 10.1002/stem.3453 |
0.643 |
|
2019 |
Bakht MK, Lovnicki JM, Tubman J, Stringer KF, Chiaramonte J, Reynolds MR, Derecichei I, Ferraiuolo RM, Fifield BA, Lubanska D, Oh SW, Cheon GJ, Kwak C, Jeong CW, Kang KW, et al. Differential expression of glucose transporters and hexokinases in prostate cancer with a neuroendocrine gene signature: a mechanistic perspective for FDG imaging of PSMA-suppressed tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31806771 DOI: 10.2967/Jnumed.119.231068 |
0.547 |
|
2017 |
Lubanska D, Porter L. Revisiting CDK Inhibitors for Treatment of Glioblastoma Multiforme. Drugs in R&D. PMID 28324583 DOI: 10.1007/S40268-017-0180-1 |
0.646 |
|
2014 |
Lubanska D, Porter LA. The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population. Oncoscience. 1: 336-48. PMID 25594028 |
0.7 |
|
2014 |
Lubanska D, Porter LA. Atypical cell cycle control over neural cell fate. Cell Cycle (Georgetown, Tex.). 13: 2987. PMID 25486555 DOI: 10.4161/15384101.2014.962849 |
0.699 |
|
2014 |
Lubanska D, Market-Velker BA, deCarvalho AC, Mikkelsen T, Fidalgo da Silva E, Porter LA. The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma. Cancer Cell. 25: 64-76. PMID 24434210 DOI: 10.1016/J.Ccr.2013.12.006 |
0.658 |
|
2014 |
Lubanska D, Porter LA. The atypical cell cycle regulator Spy1 suppresses differentiation of the neuroblastoma stem cell population Oncoscience. 1: 336-348. DOI: 10.18632/oncoscience.36 |
0.7 |
|
Show low-probability matches. |